Literature DB >> 4209275

Hypothalamic releasing factors and Parkinson disease.

T N Chase, A C Woods, M A Lipton, C E Morris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4209275     DOI： 10.1001/archneur.1974.00490370081013

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  3 in total

1.  Failure of MIF-I to affect behavioral responses in patients with Parkinson's diseases under L-dopa therapy.

Authors:  T Caraceni; E A Parati; F Girotti; I Celano; C Frigerio; D Cocchi; E E Müller
Journal:  Psychopharmacology (Berl)       Date:  1979-06-21       Impact factor: 4.530

2.  Comparison of thyrotropin-releasing hormone with melanocyte-stimulating-hormone-release-inhibiting factor as pentobarbital antagonists in monkeys.

Authors:  T J Crowley; M Hydinger
Journal:  Psychopharmacology (Berl)       Date:  1977-07-18       Impact factor: 4.530

3.  Endocrine aspects of bromocriptine therapy in Parkinsonism.

Authors:  K M Shaw; A J Lees; S Franks; P Daggett; B D Thompson; G M Stern
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.